Mark Fridlyand - Director, Strategy & Corporate Development

Por um escritor misterioso
Last updated 26 março 2025
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Director, Strategy & Corporate Development
Alex Fridlyand email address & phone number Newlight Partners Partner contact information - RocketReach
Mark Fridlyand - Director, Strategy & Corporate Development
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Mark Fridlyand - Director, Strategy & Corporate Development
SYNONYM Overview SignalHire Company Profile
Mark Fridlyand - Director, Strategy & Corporate Development
PDF) Microarray Data Analysis: From Hypotheses to Conclusions Using Gene Expression Data
Mark Fridlyand - Director, Strategy & Corporate Development
img_003.jpg
Mark Fridlyand - Director, Strategy & Corporate Development
Edward Shenderovich - Co-founder & CEO at Synonym Biotechnologies
Mark Fridlyand - Director, Strategy & Corporate Development
f1a_021.jpg
Mark Fridlyand - Director, Strategy & Corporate Development
Genentech: Mark Merchant Senior Director, Translational Oncology
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Director, Strategy & Corporate Finance at Synonym Biotechnologies

© 2014-2025 startwindsor.com. All rights reserved.